共 95 条
[1]
Travis WD(2014)Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine Thorac Surg Clin 24 257-266
[2]
Volante M(2007)Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy Mod Pathol 20 1172-1182
[3]
Brizzi MP(2001)Morphometry confirms the presence of considerable nuclear size overlap between “small cells” and “large cells” in high-grade pulmonary neuroendocrine neoplasm Am J Clin Pathol 116 466-472
[4]
Faggiano A(2006)Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis Mod Pathol 19 1358-1368
[5]
La Rosa S(2017)High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases Am J Surg Pathol 41 263-270
[6]
Rapa I(2002)Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification Arch Pathol Lab Med 126 545-553
[7]
Ferrero A(2013)Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study Ann Oncol 24 152-160
[8]
Marchevsky AM(2015)Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms Endocr Relat Cancer 22 657-664
[9]
Gal AA(2017)Treatment response and outcomes of grade 3 pancreatic neuroendocrine neoplasms based on morphology: well differentiated versus poorly differentiated Pancreas. 46 296-301
[10]
Shah S(2018)A common classification framework for neuroendocrine neoplasms: International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal Mod Pathol 31 1770-1786